Pilulka's Market Expansion and Innovation

LEGAL NOTICE This document has been prepared by Pilulka Lékárny a.s. with its registered office at Českomoravská 2408/1a, 190 00 Prague 9 (hereinafter referred to as "Pilulka" or the "Company") for the purpose of the public offering of the Company's newly issued shares, which takes place, inter alia, on the START market of Prague Stock Exchange, a.s. (hereinafter referred to as "SPO", "START market"). This Document does not constitute any recommendation to invest in any investment instruments. The presentation reflects information provided by the Company to the best of its knowledge and belief. This document does not contain definitive or exhaustive information about the Company or the Company's shares. Each recipient of this document and potential investor should consult his or her own legal, financial and other professional advisers as to the suitability of his or her investment before making any investment decision in respect of the Company's shares and should rely solely on the information about the Company contained in the prospectus for the Company's shares which has been approved in accordance with the Prospectus Regulation by a decision of the Czech National Bank out of 22 May 2023, ref. No.: 2023/062588/CNB/570 under file No. S-Sp-2023/00034/CNB/572, which became effective on 23 May 2023 (the "Prospectus"). Prospectus was published on the Company's website www.pilulka.cz/pro- investory/. The approval of the Prospectus by the Czech National Bank should not be construed as an endorsement of the Company's shares offered under the SPO. Prospective investors should properly read the Prospectus before making their investment decision in order to fully understand the potential risks and rewards associated with a decision to invest in the Company's shares. The information provided herein by the Company also includes, among other things, estimates and forecasts of future financial results that have been prepared by the Company's management. It should be taken into account, that statements about these estimates do not provide any assurance that these results will be achieved. Actual results to be realized by the Company may differ from these estimates. Many of these factors are beyond the Company's present knowledge, awareness and/or control and cannot be foreseen by the Company. No representation or warranty, express or implied, or liability or undertaking is or will be given by the Company or its shareholders or any of its subsidiaries, directors, officers, agents, employees, advisers, in relation to the accuracy, reliability or completeness of the contents of this document. The Company and its shareholders hereby expressly disclaim any responsibility or liability for the accuracy, errors or incompleteness of the information contained in this document. No information, statements or opinions contained in this document will form the basis of any future contractual relationship to which the Company is a party. This presentation does not constitute an offer or invitation to purchase or subscribe for any shares of the Company or other securities and does not constitute an offer or sale of any shares or other securities in any jurisdiction in which such offer or sale would be unlawful without appropriate approval or registration under the securities regulations of such jurisdiction. The public offer of shares under the SPO is made exclusively on the basis of the Prospectus, which is available on the Company's website. 2 +pilulka

View entire presentation